Treatment for ataxia in multiple sclerosis

Area of Science:

• Neurology
• Clinical Trials
• Evidence-Based Medicine

Background:

• Ataxia and tremor are common disabling symptoms in multiple sclerosis (MS), affecting up to 80% of patients.
• Available treatments include pharmacotherapy, stereotactic neurosurgery, and neurorehabilitation.

Purpose of the Study:

• To assess the efficacy and tolerability of pharmacological and non-pharmacological treatments for ataxia in MS patients.
• To synthesize findings from randomized controlled trials on MS ataxia treatments.

Main Methods:

• Searched multiple electronic databases (Cochrane, CENTRAL, NRR, MEDLINE, EMBASE) and conducted manual searches.
• Included blinded, randomized controlled trials (placebo-controlled or comparative).
• Data extracted by three independent reviewers; meta-analysis not performed due to study limitations.

Main Results:

• Ten randomized controlled trials met inclusion criteria: six on pharmacotherapy, four on neurosurgery/neurorehabilitation.
• Pharmacotherapies generally showed unrewarding results.
• Insufficient data exists for neurosurgery or rehabilitation to inform practice changes.

Conclusions:

• Efficacy and tolerability of MS ataxia pharmacotherapies are poorly documented, precluding treatment recommendations.
• Neurosurgery and neurorehabilitation studies show promise, but indications for use are unclear.
• Development of standardized measures and larger, well-designed trials are crucial for advancing MS ataxia treatment.